article thumbnail

Listicle: Maximising outsourcing models beyond time and cost

Drug Discovery World

CROs offer an established infrastructure to develop, initiate, execute, and progress drug discovery programs towards the clinic. Outsourcing can alleviate unnecessary backlogs and provide access to cutting-edge technologies, giving companies an edge to reach critical discovery milestones in a timely manner. Conclusion.

Reagent 52
article thumbnail

Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal

pharmaphorum

The new deal will assists the company’s focus “on advancing and innovating Parexel to meet our customers’ needs across the evolving clinical development landscape,” he added.